ElevateBio Revenue and Competitors
Estimated Revenue & Valuation
- ElevateBio's estimated annual revenue is currently $121.3M per year.
- ElevateBio's estimated revenue per employee is $217,000
- ElevateBio's total funding is $845M.
Employee Data
- ElevateBio has 559 Employees.
- ElevateBio grew their employee count by 1% last year.
ElevateBio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Information Officer | Reveal Email/Phone |
2 | Chief Information Officer | Reveal Email/Phone |
3 | Chief Staff / VP Business Development | Reveal Email/Phone |
4 | CSO, Regenerative Medicine | Reveal Email/Phone |
5 | Sr. VP Cellular Engineering | Reveal Email/Phone |
6 | VP, Business Development & Corporate Strategy | Reveal Email/Phone |
7 | VP: Head CMC Analytical Development & Operations | Reveal Email/Phone |
8 | SVP, Head IP at ElevateBio, and VP, Head IP at AlloVir | Reveal Email/Phone |
9 | VP, Clinical Operations | Reveal Email/Phone |
10 | Head, Business Development and Strategy | Reveal Email/Phone |
ElevateBio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is ElevateBio?
A New Model To Accelerate Innovation ElevateBio is creating and operating a portfolio of cell and gene therapy companies through partnerships with the worldￃﾢ￢ﾂﾬ￢ﾄﾢs most innovative scientists and inventors. Together, we leverage our internal bench-to-bedside expertise to accelerate the development and delivery of therapies ￃﾢ￢ﾂﾬ￢ﾀﾜ supported by our broad access to capital. Many Companies ￃﾢ￢ﾂﾬ￢ﾀﾜ One Robust Organization ElevateBioￃﾢ￢ﾂﾬ￢ﾄﾢs novel business model, including BaseCamp, our centralized R&D and manufacturing organization, is structured to rapidly and efficiently build single- and multi-product cell and gene therapy companies. Each portfolio company benefits from our fully-integrated capabilities, including basic and translational research, process development, cGMP manufacturing, clinical development, regulatory affairs and commercial operations.
keywords:N/A
$845M
Total Funding
559
Number of Employees
$121.3M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ElevateBio News
With $845m raised to date, ElevateBio will keep building its cell and gene therapy manufacturing capabilities and continue creating new...
Late last year, ElevateBio bought a former partner, Life Edit Therapeutics, gaining access to Life Edit's genome editing platform. The biotech...
Melissa Carpenter, PhD, Chief Scientific Officer of US-based cell & gene therapy biotech ElevateBio's Regenerative Medicine unit,...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 18, 2021-- ElevateBio, a cell and gene therapy technology company focused on powering transformative cell and gene therapies, today announced that the company’s Chief Scientific Officer of Regenerative Medicine, Dr. Melissa Carpenter, has been appointed to ...
ElevateBio has raised $525 million in a round led by Matrix Capital Management, with participation from investors including SoftBank's Vision Fund 2 and Fidelity Management & Research. Based in Massachusetts, the company is a developer of cell, gene and regenerative therapies. Select Additional ...
Other Companies in Waltham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $105.4M | 562 | 8% | N/A |
#2 | N/A | 566 | 349% | N/A |
#3 | $106.8M | 589 | N/A | N/A |
#4 | $165.7M | 593 | 2% | N/A |
#5 | $239M | 697 | 58% | $95.5M |